Table 1.
Median (IQR) or Total (%) | |
---|---|
Age | 28(24 – 33) |
Male | 32 (89%) |
Bachelor’s degree or higher | 21 (58%) |
Days post HIV transmission | 19 (15–24) |
Fiebig I/II* | 23 (64%) |
CRF01_AE | 31 (86%) |
CD4 Count (cells/mm3) | 411 (338–568) |
CDS Count (cells/mm3) | 578 (399–1013) |
Plasma HIV RNA (Iog10 copies/ml) | 5.52 (4.56–5.87) |
CSF HIV RNA (Iog10 copies/ml) | 3.37 (2.19–4.35) |
No drug use** | 26 (72%) |
Fiebig I: HIV RNA+; Fiebig II: HIV RNA+, p24 antigen +.
Denies any lifetime drug use or any drug use in 4 months prior to enrollment